SCHEMBL5481659

SCHEMBL5481659

CN(C)c1ccc(C2(c3ccc(N(C)C)cc3)C(=O)Nc3sccc32)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.35
HPGD P15428 3/20 0.35
TDP1 Q9NUW8 3/20 0.35
HSD17B10 Q99714 2/20 0.35
CYP3A4 P08684 2/20 0.35
CNR1 P21554 1/20 0.35
HTT P42858 1/20 0.35
GPR35 Q9HC97 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35
HIF1A Q16665 1/20 0.35
PIM1 P11309 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
HTR6 P50406 1/20 0.34
MAPT P10636 6/20 0.33
TSHR P16473 2/20 0.33
KAT2B Q92831 1/20 0.33
ALOX15 P16050 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
LMNA P02545 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5481733 0.80 LMNA (0.37) CYP3A4CNR1HTTGPR35GPR55
SCHEMBL5478006 0.75 HTR6 (0.40) ALDH1A1HPGDTDP1HSD17B10CYP3A4
SCHEMBL5478018 0.70 ALDH1A1 (0.38) ALDH1A1HPGDTDP1HSD17B10CYP3A4
SCHEMBL5483644 0.67 ALDH1A1 (0.33) ALDH1A1HPGDTDP1HSD17B10CYP3A4
SCHEMBL13145365 0.67 CHRM2 (0.78) ALDH1A1HPGDTDP1CYP3A4CNR1
SCHEMBL5481754 0.67 HTR6 (0.40) ALDH1A1HPGDTDP1HSD17B10CYP3A4
SCHEMBL5485875 0.66 CNR1 (0.41) ALDH1A1HPGDTDP1HSD17B10CYP3A4
SCHEMBL5488447 0.63 CNR1 (0.41) ALDH1A1HPGDTDP1HSD17B10CYP3A4
SCHEMBL16014111 0.61 ALDH1A1 (0.47) ALDH1A1HPGDTDP1HSD17B10CYP3A4
SCHEMBL19754368 0.60 ALDH1A1 (0.46) ALDH1A1HPGDTDP1HSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299102-A1 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer TOPO TARGET A/S (DK) 2007-12-27 US claimed
US-20070299102-A1 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer TOPO TARGET A/S (DK) 2007-12-27 US disclosed
EP-1734951-A2 DIPHENYL-INDOL-2-ON COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER TopoTarget A/S (DK) 2006-12-27 EP disclosed
WO-2005097107-A2 DIPHENYL - INDOL-2-ON COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER TOPOTARGET A/S (DK) 2005-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299102-A1 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer MTOR, RICTOR, CDK4 ALDH1A1 2650/4885HPGD 1829/4885TDP1 3334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.